Erratum. Liraglutide Treatment Reverses Unconventional Cellular Defects in Induced Pluripotent Stem Cell-Derived β-Cells Harboring a Partially Functional WFS1 Variant. Diabetes 2025;74:1273-1288

Articolo

Data di Pubblicazione:

2025

Citazione:

Erratum. Liraglutide Treatment Reverses Unconventional Cellular Defects in Induced Pluripotent Stem Cell-Derived β-Cells Harboring a Partially Functional WFS1 Variant. Diabetes 2025;74:1273-1288 / Torchio, S.; Siracusano, G.; Cuozzo, F.; Zamarian, V.; Pellegrini, S.; Manenti, F.; Bonfanti, R.; Frontino, G.; Sordi, V.; Chimienti, R.; Piemonti, L.. - In: DIABETES. - ISSN 1939-327X. - 74:10(2025), pp. 1885-1885. [10.2337/db25-er10a]

Abstract:

In the article cited above, TG was incorrectly introduced as transforming secretory granules in the main text. The correct term is thapsigargin. The editors apologize for the error. The online version of the article (https://doi.org/10.2337/db24-0720) has been up-dated to correct the error.

Tipologia CRIS:

1.1.5. Erratum

Elenco autori: